Menu

Finch Therapeutics Group, Inc. FNCH

Full chart Compare
Set alert

Price alert · FNCH

All alert types
10.20 USD 0.00 (+0.00%)

Aug 5, 2026, 3:47 PM EDT

10.00 Day range 10.20

52-week range unavailable

YTD
-24.39%
1 year
-25.17%

Revenue & Expenses

Other Income → Expenses: $4.08MIncome Tax Benefit → Expenses: $3.46MExpenses → Selling, General & Admin: $26.91MExpenses → Research & Development: $7.20MExpenses → Other Operating Expenses: $49.86MGross Profit → Expenses: $107.00KRevenue → Gross Profit: $107.00KNet Loss → Expenses: $74.75MOther Income$4.08MIncome Tax Benefit$3.46MGross Profit$107.00KNet Loss$74.75MExpenses$82.40MSelling, General & Admin$26.91MResearch & Development$7.20MOther Operating Expenses$49.86MRevenue$107.00K

Latest period ending Dec 31, 2023 · select a line to chart its full history

Annual income statement

FNCH annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
107.00K861.00K18.53M7.72M10.15M
107.00K861.00K18.53M7.72M10.15M
107.00K861.00K18.53M7.72M9.84M
83.97M116.45M78.52M47.16M30.98M
7.20M52.86M57.28M33.14M23.54M
26.91M36.19M21.24M14.01M7.44M
-83.86M-115.59M-59.98M-39.44M-21.14M
-1.57M-252.00K-22.00K0-488.00K
-3.46M0000
-74.75M-114.65M-58.16M-39.34M-20.75M
-74.75M-114.65M-58.16M-39.34M-20.75M
-74.75M-114.65M-58.16M-39.34M-20.75M
-74.75M-114.65M-58.16M-39.34M-20.75M
-46.59-72.12-44.40-144.90-85.20
-46.59-72.12-44.40-144.90-85.20
-46.59-72.12-44.40-144.90-85.20
-79.78M-114.90M-58.18M-39.34M-21.24M
-79.78M-114.90M-58.18M-39.34M-21.24M
1.60M1.59M1.31M271.49K243.19K
1.60M1.59M1.31M271.49K243.19K